BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16339518)

  • 1. CD80 cytoplasmic domain controls localization of CD28, CTLA-4, and protein kinase Ctheta in the immunological synapse.
    Tseng SY; Liu M; Dustin ML
    J Immunol; 2005 Dec; 175(12):7829-36. PubMed ID: 16339518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-dendritic cell immunological synapses contain TCR-dependent CD28-CD80 clusters that recruit protein kinase C theta.
    Tseng SY; Waite JC; Liu M; Vardhana S; Dustin ML
    J Immunol; 2008 Oct; 181(7):4852-63. PubMed ID: 18802089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
    Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
    J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation.
    Bhatia S; Sun K; Almo SC; Nathenson SG; Hodes RJ
    J Immunol; 2010 Feb; 184(4):1821-8. PubMed ID: 20065109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signals and sequences that control CD28 localization to the central region of the immunological synapse.
    Sanchez-Lockhart M; Graf B; Miller J
    J Immunol; 2008 Dec; 181(11):7639-48. PubMed ID: 19017952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
    J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulation of IL-2 Production through CD28 Is Dependent on the Size of Its Ligand.
    Lim HS; Cordoba SP; Dushek O; Goyette J; Taylor A; Rudd CE; van der Merwe PA
    J Immunol; 2015 Dec; 195(11):5432-9. PubMed ID: 26500347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.
    Pentcheva-Hoang T; Egen JG; Wojnoonski K; Allison JP
    Immunity; 2004 Sep; 21(3):401-13. PubMed ID: 15357951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 lacking the cytoplasmic domain costimulates IL-2 production in T-cell hybridomas.
    Hueber AJ; Matzkies FG; Rahmeh M; Manger B; Kalden JR; Nagel T
    Immunol Cell Biol; 2006 Feb; 84(1):51-8. PubMed ID: 16405652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.
    Fargeas CA; Truneh A; Reddy M; Hurle M; Sweet R; Sékaly RP
    J Exp Med; 1995 Sep; 182(3):667-75. PubMed ID: 7544393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of protein-protein interfaces implicated in CD80-CD28 costimulatory signaling.
    Sørensen P; Kussmann M; Rosén A; Bennett KL; Thrige Dda G; Uvebrant K; Walse B; Roepstorff P; Björk P
    J Immunol; 2004 Jun; 172(11):6803-9. PubMed ID: 15153498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28.
    Slavik JM; Hutchcroft JE; Bierer BE
    J Biol Chem; 1999 Jan; 274(5):3116-24. PubMed ID: 9915850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
    Ostrov DA; Shi W; Schwartz JC; Almo SC; Nathenson SG
    Science; 2000 Oct; 290(5492):816-9. PubMed ID: 11052947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase.
    Stein PH; Fraser JD; Weiss A
    Mol Cell Biol; 1994 May; 14(5):3392-402. PubMed ID: 8164687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular localization of CD80 receptors is dependent on an intact cytoplasmic tail and is required for CD28-dependent T cell costimulation.
    Doty RT; Clark EA
    J Immunol; 1996 Oct; 157(8):3270-9. PubMed ID: 8871621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
    Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
    J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.